Medicine recalls
|
| |
| Batch recall of Normosol-M & 5% Dextrose Injection |
| |
The Department of Health (DH) today (February 2) endorsed a licensed drug wholesaler, Pfizer Corporation Hong Kong Ltd (Pfizer), to recall one batch (batch number: 56-853-FW) of Normosol-M & 5% Dextrose Injection (Hong Kong registration number: HK-32659) from the market due to a printing error.
The DH was notified by Pfizer today that a complaint was received by Pfizer involving a printing error on the expiry date printed on the package of the product. The expiry date was mistakenly printed as 1 AUG 1017 instead of 1 AUG 2017. As a precautionary measure, Pfizer voluntarily recalls the above affected batch from the market.
Normosol-M & 5% Dextrose Injection (containing Dextrose and other electrolytes) is an over-the-counter medicine indicated for maintenance of body fluid and electrolytes.
According to Pfizer, about 3,394 bags (each bag containing 1,000ml) from the affected batch have been supplied to the 4 private hospitals and one private clinic. The DH has not received any adverse reaction reports related to the affected batch of this pharmaceutical product so far. The DH will closely monitor the incident.
|
| |
|
|
